Our News
First Rounders: John Maraganore
May 9, 2018
Alnylam Pharmaceuticals
Our CEO John Maraganore, Ph.D. recently chatted with the Nature Biotechnology Podcast about his path into science, through research and ultimately into biotech. He also talks about why RNAi (RNA interference) was such a strong pull for him to join Alnylam and the challenges of developing an entirely new, innovative class of medicines.
Nature Biotechnology Podcast
Tags
Perspectives, Podcasts, RNAi, Biotech, Leadership, John Maraganore
Content Types
FOLLOW US
Visit our social channels to learn more about the innovative work we are doing at Alnylam.
